The Miraki Method™
We choose to solve problems that move us and motivate us to act
Our repeatable and risk-adjusted method identifies future demands, and efficiently and effectively builds the best solutions to those pressing needs. The Miraki Method™ is a unique and efficient approach to investing that has led to the successful exits of multiple companies and created approximately $6.33 billion in capital appreciation. This six-step method allows us to translate ideas and research out of labs and build them into flourishing companies. All of our past, current and future companies advance through each stage, in succession.
UNCOVER BIG PROBLEMS
Today’s and tomorrow’s most urgent healthcare demands are identified by leveraging Miraki’s curated and vast community, knowledge base and research.
IDENTIFY ALL POSSIBILITIES
We fervently evaluate the best research, IP and possible in-house solutions. We don’t choose from existing companies that claim to have the right solution. And only after identifying the best solution do we proceed.
EVALUATE SOLUTIONS
When evaluating a solution, we establish a broad team of experts with diverse perspectives and skills. A core team is then selected to work with the portfolio company to evaluate potential solutions alongside the market’s needs and requirements.
ASSESS VALUE AND EXIT OPPORTUNITY
During our valuation and exit assessment, we analyze acquirers’ needs, demands and willingness to pay. Each portfolio company has already benefited from insights to the problems major strategics wish to solve. We will also determine potential and optimal exit points. This assessment is supported by more than 30 years of close relationships with strategics.
PROTECT 'KING' SOLUTION
At this point, one idea is declared ‘king’ as it has emerged through not only a rigorous appraisal of the market, but also an understanding of the project’s costs, timeline and risks. Intellectual property for this solution is carefully protected as we work to develop additional competitive advantages and barriers to entry.
NURTURE THROUGH SCROLL™
Our Scroll™ examines a portfolio company’s critical risk factors and defines each development milestone, categorized by functional area. These milestones are tied into the company’s operations and the schedule of funding rounds, anticipated exit values and projected IRR of each investment. In this Nurture step, risk is quantified and actively reduced, while the company’s value increases when each milestone is met.